hotspot -WSS

hotspot

author：fashion 2025-09-27 23:33:28 - browse：49244

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The aspartame in Diet Coke probably isn’t giving you cancer

WSS

EU regulator recommends expanding Mounjaro approval to obesity

Prior authorization will have to move faster under new Biden rule

NIH director takes cautious approach to Biden drug pricing priority

The aspartame in Diet Coke probably isn’t giving you cancer

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

The surgeon had a dilemma only a Nazi medical text could resolve

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

How one medical school became remarkably diverse

How digital therapeutics firms are pivoting after Pear's bankruptcy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ACA's risk program benefits Blue Cross Blue Shield insurers

The cancer drug shortage isn’t new — and neither are the solutions

Home health providers sue Medicare over payment cuts

The cancer drug shortage isn’t new — and neither are the solutions

Independent physicians launch a new lobbying group

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The tragedy of Johnson & Johnson’s Covid vaccine

focus

ACA's risk program benefits Blue Cross Blue Shield insurers

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Eli Lilly, Pfizer, and others want in on the online prescription market

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Recent heat wave in the Mediterranean caused by climate change: Study

Research misconduct: Proposed new rules face resistance

hotspot

hotspot

focus

Wikipedia